ARIZEKE PHARMACEUTICALS INC has a total of 30 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CSL BEHRING RECOMBINANT FACILITY AG, AmideBio LLC and ALTEOGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | Australia | 6 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Israel | 3 | |
#6 | Mexico | 2 | |
#7 | United States | 2 | |
#8 | China | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Nanostructure applications | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Henderson Daniel R | 8 |
#2 | Houston Lou L | 8 |
#3 | Chapin Steven J | 5 |
#4 | Houston L L | 5 |
#5 | Glynn Jacqueline M | 4 |
#6 | Basu Amaresh | 4 |
#7 | Domingo Derrick | 4 |
#8 | Chapin Steven | 4 |
#9 | Sheridan Philip Lee | 4 |
#10 | Sheridan Philip J | 4 |
Publication | Filing date | Title |
---|---|---|
WO2006060051A2 | Enzyme chimeras and methods of their use for the treatment of infection by bacillus anthracis | |
WO2004102184A1 | Compositions and methods for concentrating polypeptides and proteins | |
AU2004204764A1 | Methods of treating lung diseases | |
CN1968716A | Methods of treating lung diseases | |
US2004157330A1 | Compositions and methods for targeted biological delivery of molecular carriers | |
WO03084470A2 | Compositions and methods for targeted biological delivery of molecular carriers | |
AU2002305140A1 | Compositions and methods for transepithelial transport of membrane-bounded vesicles and virions | |
WO02074787A2 | Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic molecules | |
IL155204D0 | Compositions and methods for the transport of biologically active agents across cellular barriers | |
AU5761301A | Compositions comprising carriers and transportable complexes |